You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
權識國際(00381.HK)與河南秋之韻將共同合作開發、運營河南雲臺山養生谷

格隆匯6月11日丨權識國際(00381.HK)公告,於2025年6月11日,公司全資附屬公司僑雄(福建)投資有限公司與河南秋之韻科技有限公司(河南秋之韻)就共同合作開發、運營河南雲臺山養生谷相關事項訂立戰略合作協定。

根據戰略合作協定書,僑雄福建與河南秋之韻將共同合作開發、運營河南雲臺山養生谷,打造亞洲最大的生命科學研究院及幹細胞體驗中心。形成戰略合作,爲高端客戶羣打造集旅遊、度假及康養於一體的綜合型基地。

河南秋之韻於2023年9月在中國成立,是一家專注於生物科技研發與健康產業應用的高新技術企業。河南秋之韻立足河南中藥材資源優勢,聚焦植物活性成分提取技術開發,已建成標準化GMP生產車間,擁有超臨界CO2萃取等核心技術,產品涵蓋中藥飲片、保健食品、化妝品原料三大系列。依託雲臺山區域道地藥材種植基地,河南秋之韻創新「種植—研發—生產」全產業鏈模式,目前申請專利15項,通過ISO22000食品安全管理體系認證,致力於成爲中原地區生物健康產業標杆企業。

僑雄福建與河南秋之韻的戰略合作,是基於雙方優勢互補與雲臺山康養資源的深度整合:集團憑藉文旅項目開發經驗及20億元資產管理規模,結合河南秋之韻在植物提取領域的技術積累(擁有15項專利及GMP認證產線),共同開發雲臺山養生谷項目。

合作將實現三方價值:集團通過「輕資產+技術賦能」模式降低重資產投入風險,河南秋之韻獲得年300萬景區客流的終端市場入口,雲臺山景區則完善「藥膳療養—生態觀光—文化體驗」產業鏈,預計項目運營將帶動當地就業,成爲河南省「文旅+康養」產業融合的省級示範工程。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account